Drynaria fortunei-derived total flavonoid fraction and isolated compounds exert oestrogen-like protective effects in bone

British Journal of Nutrition

Volumn 110, Issue 3, 2013, Pages 475-485

  Wong, Ka Chun ^a   Pang, Wai Yin ^a   Wang, Xin Lun ^b,c   Mok, Sao Keng ^a   Lai, Wan Ping ^a   Chow, Hung Kay ^a   Leung, Ping Chung ^d   Yao, Xin Sheng ^c,e   Wong, Man Sau ^a,f  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^c SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^e JINAN UNIVERSITY   (China)

^f State Key Laboratory of Chinese Medicine and Molecular Pharmacology (Incubation)   (China)

Author keywords

Bone properties; Drynaria fortunei; Naringin; Oestrogen receptors; Osteoblasts; Total flavonoids

Indexed keywords

5,7 DIHYDROXYCHROMONE NEOHESPERIDOSIDE; 5,7,3',5' TETRAHYDROXYFLAVONE; ALKALINE PHOSPHATASE; AURANTIIN; CALCIUM; CHROMONE DERIVATIVE; DRYNARIA FORTUNEI EXTRACT; ESTRADIOL; ESTROGEN RECEPTOR; FLAVONE DERIVATIVE; FLAVONOID; FULVESTRANT; MESSENGER RNA; NEOHESPERIDIN; OSTEOPROTEGERIN; PHOSPHATE; PLANT EXTRACT; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BLOOD ANALYSIS; BONE DENSITY; BONE STRENGTH; CELL FUNCTION; CELL PROLIFERATION; CHINESE HERB; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MEGADOSE; DRUG STRUCTURE; DRYNARIA FORTUNEI; ENZYME ACTIVITY; ESTROGEN ACTIVITY; FEMALE; FEMUR; LOW DRUG DOSE; LUMBAR SPINE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; OVARIECTOMY; POLYPODIACEAE; PROTEIN EXPRESSION; RAT; TIBIA; URINALYSIS;

ALKALINE PHOSPHATASE; ANIMALS; BONE AND BONES; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; ESTRADIOL; FEMALE; FEMUR; FLAVANONES; FLAVONOIDS; LUMBAR VERTEBRAE; MICE; MICE, INBRED C57BL; OSTEOBLASTS; OSTEOCLASTS; OSTEOPOROSIS; OSTEOPROTEGERIN; OVARIECTOMY; PHYTOESTROGENS; PHYTOTHERAPY; PLANT EXTRACTS; POLYPODIACEAE; RATS; RNA, MESSENGER; TIBIA;

EID: 84880775163     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114512005405     Document Type: Article

References (48)

1. Banu J, Varela E & Fernandes G (2012) Alternative therapies for the prevention and treatment of osteoporosis. Nutr Rev 70, 22-40.
2. Khosla S (2010) Update on estrogens and the skeleton. J Clin Endocrinol Metab 95, 3569-3577.
3. Al-Anazi AF, Qureshi VF, Javaid K, et al. (2011) Preventive effects of phytoestrogens against postmenopausal osteoporosis as compared to the available therapeutic choices: an overview. J Nat Sci Biol Med 2, 154-163.
4. Gass M & Dawson-Hughes B (2006) Preventing osteoporosis-related fractures: an overview. Am J Med 119, S3-S11.
5. Cassidy A (2003) Dietary phytoestrogens and bone health. J Br Menopause Soc 9, 17-21.
6. Zhang Y, Chen WF, Lai WP, et al. (2008) Soy isoflavones and their bone protective effects. Inflammopharmacology 16, 213-215.
7. Zhang Y, Li Q, Wan HY, et al. (2009) Genistein and a soy extract differentially affect three-dimensional bone parameters and bone-specific gene expression in ovariectomized mice. J Nutr 139, 2230-2236.
8. Lampe JW (2003) Isoflavonoid and lignan phytoestrogens as dietary biomarkers. J Nutr 133, Suppl. 3, 956S-964S.
9. Mok SK, Chen WF, Lai WP, et al. (2010) Icariin protects against bone loss induced by oestrogen deficiency and activates oestrogen receptor-dependent osteoblastic functions in UMR 106 cells. Br J Pharmacol 159, 939-949.
10. Pang WY, Wang XL, Mok SK, et al. (2010) Naringin improves bone properties in ovariectomized mice and exerts oestrogen-like activities in rat osteoblast-like (UMR-106) cells. Br J Pharmacol 159, 1693-1703.
11. Mei J, Yeung SSC & Kung AWC (2001) High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women. J Clin Endocrinol Metab 86, 5217-5221.
12. Zhang Y, Li Q, Li X, et al. (2010) Erythrina variegata extract exerts osteoprotective effects by suppression of the process of bone resorption. Br J Nutr 104, 965-971.
13. Chen WF, Mok SK, Wang XL, et al. (2011) Total flavonoid fraction of the Herba epimedii extract suppresses urinary calcium excretion and improves bone properties in ovariectomised mice. Br J Nutr 105, 180-189.
14. Zhang Y, Li Q, Wan HY, et al. (2011) Study of the mechanisms by which Sambucus williamsii HANCE extract exert protective effects against ovariectomy-induced osteoporosis in vivo. Osteoporos Int 22, 703-709.
15. Zhou Q (2003) Clinical application of Drynaria in orthopedics and traumatology. J Tradit Chin Orthop Traumatol 15, 59.
16. Sun JS, Dong GC, Lin CY, et al. (2003) The effect of Gu-Sui-Bu (Drynaria fortunei J. Sm) immobilized modified calcium hydrogenphosphate on bone cell activities. Biomaterials 24, 873-882.
17. Jeong JC, Lee JW, Yoon CH, et al. (2004) Drynariae rhizoma promotes osteoblast differentiation and mineralization in MC3T3-E1 cells through regulation of bone morphogenetic protein-2, alkaline phosphatase, type I collagen and collagenase-1. Toxicol In Vitro 18, 829-834.
18. Jeong JC, Lee JW, Yoon CH, et al. (2005) Stimulative effects of Drynariae rhizoma extracts on the proliferation and differentiation of osteoblastic MC3T3-E1 cells. J Ethnopharmacol 96, 489-495.
19. Jeong JCLB, Yoon CH, Kim HM, et al. (2005) Effects of Drynariae rhizoma on the proliferation of human bone cells and the immunomodulatory activity. Pharm Res 51, 125-136.
20. Wong RW & Rabie AB (2006) Systemic effect of crude extract from rhizome of Drynaria fortunei on bone formation in mice. Phytother Res 20, 313-315.
21. Wong RW, Rabie B, Bendeus M, et al. (2007) The effects of rhizoma Curculiginis and rhizoma Drynariae extracts on bones. Chin Med 2, 13.
22. Sun JHW & Liu K (2008) The research of Drynaria total flavonoids and osteoporosis research. Chin J Osteo 14, 763-766.
23. Chen LLLL, Ding PH, Tang Q, et al. (2011) Osteogenic effect of Drynariae rhizome extracts and naringin on MC3T3-E1 cells and an induced rat alveolar bone resorption model. Arch Oral Biol 56, 1655-1662.
24. Guo D, Wang J, Wang X, et al. (2011) Double directional adjusting estrogenic effect of naringin from rhizoma Drynariae (Gusuibu). J Ethnopharmacol 138, 451-457.
25. Jeong JC, Kang SK, Youn CH, et al. (2003) Inhibition of Drynariae rhizoma extracts on bone resorption mediated by processing of cathepsin K in cultured mouse osteoclasts. Int Immunopharmacol 3, 1685-1697.
26. Wang XL, Wang NL, Zhang Y, et al. (2008) Effects of eleven flavonoids from the osteoprotective fraction of Drynaria fortunei (KUNZE) J. SM. on osteoblastic proliferation using an osteoblast-like cell line. Chem Pharm Bull (Tokyo) 56, 46-51.
27. Eun Ju Chang WJL, Sung Hee Cho, Sang Won Choi. (2003) Proliferative effects of flavan-3-ols and propelargonidins from rhizomes of Drynaria fortunei on MCF-7 and osteoblastic cells. Arch Pharm Res 26, 620-630.
28. Wang XL, Wang NL, Gao H, et al. (2010) Phenylpropanoid and flavonoids from osteoprotective fraction of Drynaria fortunei. Nat Prod Res 24, 1206-1213.
29. Wang X, Zhen L, Zhang G, et al. (2011) Osteogenic effects of flavonoid aglycones from an osteoprotective fraction of Drynaria fortunei-an in vitro efficacy study. Phytomedicine 18, 868-872.
30. Wang XLWN, Wong MS & Yao XS (2008) Phenylpropanoid compounds isolated from Drynaria fortunei and their proliferation effects on UMR 106 cells. J Shenyang Pharm Univ 25, 24-29.
31. Lu Y, Zhang C, Bucheli P, et al. (2006) Citrus flavonoids in fruit and traditional Chinese medicinal food ingredients in China. Plant Foods Hum Nutr 61, 57-65.
32. Wei M, Yang Z, Li P, et al. (2007) Anti-osteoporosis activity of naringin in the retinoic acid-induced osteoporosis model. Am J Chin Med 35, 663-667.
33. Mandadi K, Ramirez M, Jayaprakasha GK, et al. (2009) Citrus bioactive compounds improve bone quality and plasma antioxidant activity in orchidectomized rats. Phytomedicine 16, 513-520.
34. Wu JB, Fong YC, Tsai HY, et al. (2008) Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt, c-Fos/c-Jun and AP-1 pathway in osteoblasts. Eur J Pharmacol 588, 333-341.
35. Li L, Zeng Z & Cai G (2011) Comparison of neoeriocitrin and naringin on proliferation and osteogenic differentiation in MC3T3-E1. Phytomedicine 18, 985-989.
36. Xie F, Wu CF, Lai WP, et al. (2005) The osteoprotective effect of Herba epimedii (HEP) extract in vivo and in vitro. Evid Based Complement Alternat Med 2, 353-361.
37. Wong RW & Rabie AB (2006) Effect of naringin on bone cells. J Orthop Res 24, 2045-2050.
38. Chang EJ, Lee WJ, Cho SH, et al. (2003) Proliferative effects of flavan-3-ols and propelargonidins from rhizomes of Drynaria fortunei on MCF-7 and osteoblastic cells. Arch Pharm Res 26, 620-630.
39. Kosuge K, Mitsunaga K, Koike K, et al. (1994) Studies on the constituents of Ailanthus integrifolia. Chem Pharm Bull (Tokyo) 42, 1669-1671.
40. Gasser JA & Willnecker J (2012) Bone measurements by peripheral quantitative computed tomography in rodents. Methods Mol Biol 816, 477-498.
41. Zhang Y, Leung PC, Che CT, et al. (2008) Improvement of bone properties and enhancement of mineralization by ethanol extract of Fructus Ligustri Lucidi. Br J Nutr 99, 494-502.
42. Lau WS, Chan RY, Guo DA, et al. (2008) Ginsenoside Rg1 exerts estrogen-like activities via ligand-independent activation of ERalpha pathway. J Steroid Biochem Mol Biol 108, 64-71.
43. Xie Y-M, Xu Y-G, Zhao J-N, et al. (2004) Effect of osteopractic total flavone on density of bones of rats without ovaria and levels. China J Basic Med Tradit Chin Med 10, 34-37.
44. Zhang J, Li HP, Yang PL, et al. (2009) Effects of total flavonoids from rhizoma Drynariae medicated serum on proliferation, differentiation, cell cycle and apoptosis of osteoblasts in vitro. Zhong Yao Cai 32, 1090-1093.
45. Pang WYWX, Mok SK, Lai WP, et al. (2010) Naringin activates estrogen receptor ligand-independently in rat osteoblast-like (UMR 106) cells and improves bone properties in ovariectomized mice. Br J Pharmacol 159, 1693-1703.
46. Bord S, Ireland DC, Beavan SR, et al. (2003) The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts. Bone 32, 136-141.
47. Chen XW, Garner SC & Anderson JJ (2002) Isoflavones regulate interleukin-6 and osteoprotegerin synthesis during osteoblast cell differentiation via an estrogen-receptordependent pathway. Biochem Biophys Res Commun 295, 417-422.
48. Zhu H, Wang WJ & Wang ZM (2010) Effects of Drynariae rhizoma total flavone on Smad1 Smad5 mRNA expression in osteoporosis. Chin Arch Trad Chin Med 28, 200-204.